📰 Mark Neumann News
Mark Neumann News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Neumann. Real-time updates on events, politics, business and more.
May 29, 2024
The 'Red to Blue' investment is an attempt for Democrats to regain control of the House
May 5, 2024
City officials have presented a synthetic turf feasibility review to the Parks and Recreation Commission.
April 30, 2024
Oklahoma City -- Brightmusic Chamber Ensemble ends its regular season concerts with three works in the Romantic style TONIGHT at 7:30 p.m. (Tuesday, April 30) at First Baptist Church in
March 29, 2024
Barca, 68, told the Wisconsin State Journal Friday he is considering running for the congressional district currently held by U.S. Rep. Bryan Steil, R-Janesville.
March 29, 2024
Barca, 68, told the Wisconsin State Journal Friday he is considering running for the congressional district currently held by U.S. Rep. Bryan Steil, R-Janesville.
March 28, 2024
MADISON, Wis. -- The leader of Wisconsins Department of Revenue will step down next month, Gov. Tony Evers announced Thursday.
February 23, 2024
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2023 Earnings Call Transcript February 22, 2024 Intra-Cellular Therapies, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.44. Intra-Cellular Therapies, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and […]
February 23, 2024
Intra-Cellular Therapies, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.44. Intra-Cellular Therapies, Inc.
February 4, 2024
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eleven analysts that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average 1-year target price […]
January 28, 2024
AdvisorShares Investments LLC grew its holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 22.4% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 5,772 shares of the biopharmaceutical company’s stock after buying an additional 1,057 shares during the quarter. AdvisorShares […]